Viridian Therapeutics
VRDN
18.28
+0.06
+0.33%
Viridian Therapeutics
US · VRDN
#2731 by market cap
Listed 1970
18.28
+0.06
+0.33%
Live - 5344 symbols - heartbeat 84s ago
· 2026-10-07 21:23
After-hours
18.22
-0.33%
Overnight
18.07
-1.15%
- Market cap
- 2.07B
- P/E (TTM)i
- -5.38
- P/Bi
- 3.67
- EPSi
- -3.32
- Div yieldi
- 0.00%
- 52W posi
- 24%
Reader sentiment
Are you bullish or bearish on VRDN?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 12 analysts
Buy
Avg price target
34.11 +86.6%
Price target rangecurrent 18.28
Low22.00
Avg34.11
High41.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-02 | LifeSci Capital | -- | BUY | 35.00 |
| 2026-09-22 | RBC Capital | -- | BUY | 38.00 |
| 2026-09-01 | Truist Financial | -- | BUY | -- |
| 2026-08-19 | Goldman Sachs | -- | BUY | 40.00 |
| 2026-08-13 | Stifel | -- | BUY | 40.00 |
| 2026-08-11 | Truist Financial | -- | BUY | 39.00 |
| 2026-08-10 | Evercore | -- | BUY | 26.00 |
| 2026-08-07 | Truist Financial | -- | BUY | 39.00 |
| 2026-08-06 | TD Cowen | -- | BUY | -- |
| 2026-08-06 | LifeSci Capital | -- | BUY | 35.00 |
| 2026-08-06 | William Blair | -- | BUY | -- |
| 2026-08-06 | Wedbush | -- | BUY | 41.00 |
| 2026-08-06 | Needham | -- | BUY | 34.00 |
| 2026-08-06 | H.C. Wainwright | -- | BUY | 22.00 |
| 2026-08-06 | RBC Capital | -- | BUY | 36.00 |
| 2026-08-04 | Wedbush | -- | BUY | 43.00 |
| 2026-07-20 | Wells Fargo | -- | BUY | 31.00 |
| 2026-07-13 | Wedbush | -- | BUY | 43.00 |
| 2026-06-30 | Wells Fargo | -- | BUY | 31.00 |
| 2026-06-30 | Truist Financial | -- | BUY | 38.00 |
| 2026-06-30 | Wedbush | -- | BUY | 43.00 |
| 2026-06-30 | Jefferies | -- | BUY | 30.00 |
| 2026-06-30 | Stifel | -- | BUY | 40.00 |
| 2026-06-29 | Wells Fargo | -- | BUY | 31.00 |
| 2026-06-29 | LifeSci Capital | -- | BUY | 35.00 |
Quant vs Street three independent views, side by side
StockVane factor grade
C+
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 1 upgrade vs 0 downgrades among tracked analyst rating changes.
- Most recent: Wells Fargo moved from Hold to Buy on 2026-06-29.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-06-29 | Wells Fargo | HOLD → BUY | 31.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2024/Q1 | 2024-05-08 | -- | ±13.14% | -1.59% (in line) |
| 2023/Q1 | 2023-05-09 | After close | ±22.78% | -1.21% (in line) |
| 2022/Q4 | 2023-03-08 | -- | ±15.86% | -10.48% (in line) |
| 2022/Q3 | 2022-11-14 | -- | ±19.94% | -0.93% (in line) |
| 2022/Q2 | 2022-08-15 | -- | -- | +49.36% |
| 2022/Q1 | 2022-05-12 | -- | ±11.36% | +28.03% (beat) |
| 2021/Q4 | 2022-03-10 | -- | ±23.63% | +5.46% (in line) |
| 2020/Q4 | 2021-03-25 | After close | -- | +4.75% |
| 2020/Q2 | 2020-08-05 | -- | -- | -6.84% |
| 2020/Q1 | 2020-05-07 | -- | -- | +7.27% |
| 2019/Q4 | 2020-03-11 | After close | -- | -16.65% |
| 2019/Q3 | 2019-11-07 | After close | -- | +0.55% |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-07 21:23:26 · For reference only, not investment advice and not tailored to your situation.